Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Lung Neoplasms 27Neoplasms 7Neoplasm Metastasis 6Colorectal Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Pancreatic Neoplasms 4Mesothelioma, Malignant 3Melanoma 3Colonic Neoplasms 3Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Non-squamous Non-small Cell Lung Cancer 2Neoplasms by Site 2Mesothelioma 2Meningeal Carcinomatosis 2Esophageal Neoplasms 2Endometrial Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma of Lung 2Vaccinia 1Uterine Cervical Neoplasms 1Thoracic Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1

Interventions

pembrolizumab 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Pemetrexed × 30 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡